دورية أكاديمية

Protective Effect of Curcumin against Sodium Salicylate-Induced Oxidative Kidney Damage, Nuclear Factor-Kappa Dysregulation, and Apoptotic Consequences in Rats.

التفاصيل البيبلوغرافية
العنوان: Protective Effect of Curcumin against Sodium Salicylate-Induced Oxidative Kidney Damage, Nuclear Factor-Kappa Dysregulation, and Apoptotic Consequences in Rats.
المؤلفون: Abd-Elhakim YM; Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44519, Egypt., Moselhy AAA; Department of Anatomy and Embryology, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44519, Egypt., Aldhahrani A; Clinical Laboratory Sciences Department, Turabah University College, Taif University, Turabah 21995, Saudi Arabia., Beheiry RR; Department of Histology and Cytology, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44519, Egypt., Mohamed WAM; Department of Clinical Pathology, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44519, Egypt., Soliman MM; Clinical Laboratory Sciences Department, Turabah University College, Taif University, Turabah 21995, Saudi Arabia., Saffaf BA; Pharmacology Department, Faculty of Pharmacy, Future University, City of the Future 41639, Egypt., M El Deib M; Department of Biochemistry, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44519, Egypt.
المصدر: Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2021 May 21; Vol. 10 (6). Date of Electronic Publication: 2021 May 21.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101668981 Publication Model: Electronic Cited Medium: Print ISSN: 2076-3921 (Print) Linking ISSN: 20763921 NLM ISO Abbreviation: Antioxidants (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2012]-
مستخلص: This study examined the effect of sodium salicylates (SS), alone and in combination with curcumin (CUR), on kidney function and architecture in rats. Five rat groups were given 1 mL physiological saline/rat orally, 1 mL olive oil/rat orally, 50 mg CUR/kg bwt orally, 300 mg SS/kg bwt intraperitoneally, or CUR+SS for 15 days. The hematological indices, serum protein profile, serum electrolytes balance, oxidative stress, and lipid peroxidation of kidney tissues were assessed. The histopathological examination and immune expression of Caspase-3 and nuclear factor kappa (NF-κB) were conducted. The findings showed that SS injection induced nephrotoxic activity, including increased serum urea, creatinine, and uric acid levels. It also caused apparent pathological alterations with increased Caspase-3 and NF-κB immuno-expression. In addition, thrombocytopenia, leukocytosis, neutrophilia, hyponatremia, hypochloremia, hypocalcemia, and hypomagnesemia but not hyperkalemia and hyperphosphatemia were evident in SS-injected rats. Moreover, SS exposure increased serum α1 globulin, renal tissue malondialdehyde, and Caspase-3 levels but superoxide dismutase, glutathione peroxidase, and Bcl-2 levels declined. Meanwhile, CUR significantly counteracted the SS harmful impacts on kidneys but SS+CUR co-administration induced an anemic condition. Overall, CUR has an evident protective role against SS-induced renal damage, but the disturbed hematological alterations should be carefully taken into consideration in their combined use.
References: Am J Kidney Dis. 2007 Sep;50(3):463-7. (PMID: 17720526)
Toxicology. 2007 Jun 3;235(1-2):83-91. (PMID: 17433521)
Toxicol Pathol. 2007 Feb;35(2):242-51. (PMID: 17366318)
Biomed Pharmacother. 2020 Nov;131:110761. (PMID: 33152924)
Int J Mol Sci. 2019 Aug 03;20(15):. (PMID: 31382550)
J Vet Diagn Invest. 2008 Jul;20(4):393-413. (PMID: 18599844)
Saudi Pharm J. 2021 Feb;29(2):194-200. (PMID: 33679180)
Toxicol Appl Pharmacol. 1986 Jun 30;84(2):241-9. (PMID: 3715872)
Blood. 2009 Jan 8;113(2):270-1. (PMID: 19131557)
Hear Res. 2008 Feb;236(1-2):42-51. (PMID: 18222054)
Toxicology. 2019 May 1;419:11-23. (PMID: 30885738)
Food Chem Toxicol. 2001 Jun;39(6):541-7. (PMID: 11346483)
Sci Rep. 2016 Apr 12;6:24428. (PMID: 27068004)
Ann N Y Acad Sci. 1964 Dec 28;121:321-49. (PMID: 14240533)
J Biosci Bioeng. 2013 May;115(5):547-51. (PMID: 23245727)
Food Chem Toxicol. 2017 Jan;99:103-118. (PMID: 27899301)
Life Sci. 2021 Feb 1;266:118869. (PMID: 33309722)
J Lab Clin Med. 1967 Jul;70(1):158-69. (PMID: 6066618)
J Pharm Pharmacol. 1994 Dec;46(12):1013-6. (PMID: 7714712)
Am Fam Physician. 2005 Jan 1;71(1):105-12. (PMID: 15663032)
Med Chem. 2007 Sep;3(5):469-74. (PMID: 17897073)
Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):32-41. (PMID: 15650394)
Biomed Pharmacother. 2018 Oct;106:1188-1194. (PMID: 30119187)
Int J Oncol. 2003 Aug;23(2):503-8. (PMID: 12851702)
Arch Gerontol Geriatr. 2014 Sep-Oct;59(2):227-33. (PMID: 25063588)
Biochem Biophys Res Commun. 1972 Jan 31;46(2):849-54. (PMID: 4400444)
Clin Toxicol (Phila). 2007;45(2):95-131. (PMID: 17364628)
J Clin Chem Clin Biochem. 1977 Dec;15(12):715-8. (PMID: 604424)
Int J Cancer. 2010 Apr 1;126(7):1771-5. (PMID: 19830693)
Biofactors. 2020 Jan;46(1):5-20. (PMID: 31580521)
Exp Toxicol Pathol. 2012 Jul;64(5):487-93. (PMID: 21130633)
Food Chem Toxicol. 2020 Nov;145:111699. (PMID: 32858134)
Int J Hematol Oncol Stem Cell Res. 2013;7(4):34-9. (PMID: 24505541)
Nutrients. 2019 Aug 08;11(8):. (PMID: 31398884)
Arch Med Res. 2020 Jan;51(1):32-40. (PMID: 32086107)
Kidney Int. 1996 Jan;49(1):181-9. (PMID: 8770966)
Life Sci. 2021 Jan 15;265:118824. (PMID: 33278387)
Anal Biochem. 1979 Jun;95(2):351-8. (PMID: 36810)
Biomed Chromatogr. 2017 Feb;31(2):. (PMID: 27390106)
Clin Chim Acta. 1972 May;38(2):475-6. (PMID: 5026368)
Food Chem Toxicol. 2013 Nov;61:28-35. (PMID: 23376509)
Am J Cardiol. 2021 Apr 1;144 Suppl 1:S15-S22. (PMID: 33706985)
PeerJ. 2019 Aug 2;7:e7429. (PMID: 31396457)
Chem Biol Interact. 2018 Oct 1;294:56-64. (PMID: 30138604)
Biochem Biophys Rep. 2018 Dec 13;17:97-107. (PMID: 30582014)
Curr Med Chem. 2007;14(7):745-57. (PMID: 17346160)
Z Klin Chem Klin Biochem. 1967 Mar;5(2):93-4. (PMID: 5605219)
Biochem Biophys Res Commun. 2020 Jun 4;526(3):786-792. (PMID: 32268959)
Clin Chem. 1981 Oct;27(10):1642-50. (PMID: 6169466)
Trends Pharmacol Sci. 2009 Jul;30(7):333-4. (PMID: 19523696)
J Biol Chem. 2016 Oct 28;291(44):22949-22960. (PMID: 27629417)
Biochem Pharmacol. 1996 Jan 12;51(1):39-45. (PMID: 8534266)
Eur J Pharmacol. 2011 Nov 30;670(2-3):578-85. (PMID: 21925163)
Front Pharmacol. 2021 Apr 27;12:651497. (PMID: 33986679)
Clin Chem. 1963 Feb;9:102-8. (PMID: 14023392)
Fiziol Zh SSSR Im I M Sechenova. 1990 Nov;76(11):1557-62. (PMID: 1964426)
Am J Clin Pathol. 1972 Oct;58(4):376-82. (PMID: 4640296)
Toxicol Appl Pharmacol. 1985 Nov;81(2):337-47. (PMID: 4060159)
Food Chem Toxicol. 2010 Nov;48(11):3246-61. (PMID: 20804811)
Nurs Clin North Am. 2018 Dec;53(4):469-480. (PMID: 30388973)
Neurotox Res. 2013 Oct;24(3):307-19. (PMID: 23494753)
Eur J Med Chem. 2016 Feb 15;109:23-35. (PMID: 26748069)
Biochem Pharmacol. 2000 Jan 1;59(1):13-23. (PMID: 10605930)
Anticancer Res. 2015 Dec;35(12):6373-8. (PMID: 26637846)
Int J Biochem Cell Biol. 2009 Jan;41(1):40-59. (PMID: 18662800)
J Agric Food Chem. 2001 May;49(5):2539-47. (PMID: 11368633)
Crit Rev Food Sci Nutr. 2019;59(1):89-101. (PMID: 28799796)
Life Sci. 2020 Aug 1;254:117782. (PMID: 32407847)
PLoS One. 2019 Sep 19;14(9):e0222836. (PMID: 31536588)
Gene. 2021 Jan 5;764:145083. (PMID: 32860902)
Physiol Rev. 2002 Jan;82(1):47-95. (PMID: 11773609)
J Ethnopharmacol. 2020 Dec 5;263:113209. (PMID: 32738390)
Analyst. 1972 Feb;97(151):142-5. (PMID: 5037807)
Clin Lab Med. 2016 Dec;36(4):761-776. (PMID: 27842792)
Curr Pharm Des. 2016;22(28):4386-97. (PMID: 27229723)
Res Commun Chem Pathol Pharmacol. 1993 Jul;81(1):77-89. (PMID: 8105522)
J Neurosci Res. 2009 Jun;87(8):1832-40. (PMID: 19185019)
Mol Cell Biochem. 1995 May 10;146(1):35-7. (PMID: 7651374)
Complement Ther Med. 2020 Jan;48:102283. (PMID: 31987259)
Food Chem Toxicol. 2018 Apr;114:34-40. (PMID: 29421648)
Kidney Blood Press Res. 2005;28(5-6):307-10. (PMID: 16534226)
J Appl Microbiol. 2009 Mar;106(3):903-8. (PMID: 19191959)
Hear Res. 2010 Jun 14;265(1-2):63-9. (PMID: 20214971)
Kidney Blood Press Res. 1998;21(6):425-31. (PMID: 9933827)
Nefrologia. 2008;28 Suppl 3:87-93. (PMID: 19018744)
Int J Mol Med. 2005 Nov;16(5):841-9. (PMID: 16211253)
Int J Biochem Cell Biol. 2004 Oct;36(10):1967-80. (PMID: 15203111)
Antioxid Redox Signal. 2014 Mar 1;20(7):1126-67. (PMID: 23991888)
Ecotoxicol Environ Saf. 2019 Nov 15;183:109467. (PMID: 31374384)
J Biol Chem. 1949 Feb;177(2):751-66. (PMID: 18110453)
Eur J Pharmacol. 2002 Jun 28;447(1):1-9. (PMID: 12106797)
Neurosci Lett. 2021 Mar 16;747:135705. (PMID: 33548408)
Toxicology. 1991 Mar 11;66(3):297-311. (PMID: 2011854)
Blood. 2009 Jan 8;113(2):462-9. (PMID: 18815282)
Ren Fail. 2016 Nov;38(10):1741-1748. (PMID: 27758164)
Appl Physiol Nutr Metab. 2015 Oct;40(10):1061-7. (PMID: 26398443)
معلومات مُعتمدة: TURSP-2020/197 Taif University
فهرسة مساهمة: Keywords: Caspase-3; NF-kappa B; anemia; curcumin; kidney; sodium salicylate
تواريخ الأحداث: Date Created: 20210602 Latest Revision: 20240402
رمز التحديث: 20240402
مُعرف محوري في PubMed: PMC8224369
DOI: 10.3390/antiox10060826
PMID: 34064189
قاعدة البيانات: MEDLINE
الوصف
تدمد:2076-3921
DOI:10.3390/antiox10060826